These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 16261561)

  • 1. Recurrent ependymoma treated with high-dose tamoxifen in a peripubertal female: Impact on tumor and the pituitary-ovarian axis.
    Yoffe R; Khakoo Y; Dunkel IJ; Souweidane M; Lis E; Sklar C
    Pediatr Blood Cancer; 2007 Oct; 49(5):758-60. PubMed ID: 16261561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian cyst formation in two pre-menopausal patients treated with tamoxifen for breast cancer.
    Shulman A; Cohen I; Altaras MM; Maymon R; Ben-Nun I; Tepper R; Beyth Y
    Hum Reprod; 1994 Aug; 9(8):1427-9. PubMed ID: 7989499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracavitary chemotherapy (Gliadel) and oral low-dose etoposide for recurrent anaplastic ependymoma.
    Sardi I; Sanzo M; Giordano F; Sandri A; Mussa F; Donati PA; Genitori L
    Oncol Rep; 2008 May; 19(5):1219-23. PubMed ID: 18425379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen-associated ovarian cysts may be endometriomas.
    Thylan S
    Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):752-3. PubMed ID: 8828450
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ovarian hyperstimulation in women with fibrocystic mammary dysplasia treated with tamoxifen].
    Gallardo M; Vaccaro H
    Rev Chil Obstet Ginecol; 1993; 58(4):328-9. PubMed ID: 7991853
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.
    Holm C; Rayala S; Jirström K; Stål O; Kumar R; Landberg G
    J Natl Cancer Inst; 2006 May; 98(10):671-80. PubMed ID: 16705121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood intracranial ependymoma: twenty-year experience from a single institution.
    Shu HK; Sall WF; Maity A; Tochner ZA; Janss AJ; Belasco JB; Rorke-Adams LB; Phillips PC; Sutton LN; Fisher MJ
    Cancer; 2007 Jul; 110(2):432-41. PubMed ID: 17559078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer.
    Meijer D; Jansen MP; Look MP; Ruigrok-Ritstier K; van Staveren IL; Sieuwerts AM; van Agthoven T; Foekens JA; Dorssers LC; Berns EM
    Breast Cancer Res Treat; 2009 Jan; 113(2):253-60. PubMed ID: 18299979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
    Kennecke H; McArthur H; Olivotto IA; Speers C; Bajdik C; Chia SK; Ellard S; Norris B; Hayes M; Barnett J; Gelmon KA
    Cancer; 2008 Apr; 112(7):1437-44. PubMed ID: 18286526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
    Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N
    Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximally safe resection followed by hypofractionated re-irradiation for locally recurrent ependymoma in children.
    Liu AK; Foreman NK; Gaspar LE; Trinidad E; Handler MH
    Pediatr Blood Cancer; 2009 Jul; 52(7):804-7. PubMed ID: 19260098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer.
    Rokavec M; Schroth W; Amaral SM; Fritz P; Antoniadou L; Glavac D; Simon W; Schwab M; Eichelbaum M; Brauch H
    Cancer Res; 2008 Dec; 68(23):9799-808. PubMed ID: 19047159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.
    Kirkegaard T; McGlynn LM; Campbell FM; Müller S; Tovey SM; Dunne B; Nielsen KV; Cooke TG; Bartlett JM
    Clin Cancer Res; 2007 Mar; 13(5):1405-11. PubMed ID: 17332282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
    Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
    Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypoid endometriosis and other benign gynaecological complications associated with Tamoxifen therapy-a case to illustrate features on magnetic resonance imaging.
    Kraft JK; Hughes T
    Clin Radiol; 2006 Feb; 61(2):198-201. PubMed ID: 16439226
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune gene and cell enrichment is associated with a good prognosis in ependymoma.
    Donson AM; Birks DK; Barton VN; Wei Q; Kleinschmidt-Demasters BK; Handler MH; Waziri AE; Wang M; Foreman NK
    J Immunol; 2009 Dec; 183(11):7428-40. PubMed ID: 19917695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen.
    Paik S
    Oncologist; 2007 Jun; 12(6):631-5. PubMed ID: 17602054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage treatment for childhood ependymoma after surgery only: Pitfalls of omitting "at once" adjuvant treatment.
    Massimino M; Giangaspero F; Garrè ML; Genitori L; Perilongo G; Collini P; Riva D; Valentini L; Scarzello G; Poggi G; Spreafico F; Peretta P; Mascarin M; Modena P; Sozzi G; Bedini N; Biassoni V; Urgesi A; Balestrini MR; Finocchiaro G; Sandri A; Gandola L;
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1440-5. PubMed ID: 16863927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.